Radiotherapy of Head and Neck Cancer With SIB

Recruiting now

Conditions studied: Quality of Life (QOL), Head and Neck Cancer, Radiotherapy Side Effect, Radiotherapy, Conformal (IMRT)

In brief

Title: Simultaneous Integrated Boost in Primary and Adjuvant Therapy of Head and Neck Tumors: Quality Control Registry Prospective Longitudinal Observational Study Short Title: Radiotherapy for Head and Neck Tumors with SIB Objective: To evaluate the efficacy and safety of definitive and adjuvant radio(chemo)therapy with simultaneous integrated boost (SIB) in patients with head and neck cancers. The study aims to assess local and regional control, overall survival, metastasis-free survival, therapy-related toxicities, and quality of life. Study Design: A prospective, longitudinal, non-interventional registry study documenting real-world outcomes and quality measures of therapy applied according to existing clinical guidelines.

Key facts

Study ID

NCT06831903

Run by

Wuerzburg University Hospital

People needed

750

Starts

2019-05-21

Expected to finish

2039-10-01

Last updated by the study team

2025-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 and older with histologically confirmed malignant head and neck tumors, undergoing definitive or adjuvant radio(chemo)therapy at the University Hospital Würzburg

You may not qualify if…

• missing informed consent
• mental or physical disorders leading to inability to understand and/or fill the quationary
• judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures

Where it is running

• University Clinic of Wuerzburg — Würzburg, Bavaria, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.